# 口服注射器市场

> 口服注射器市场研究报告按材料（聚丙烯、聚乙烯、尼龙、聚碳酸酯）、按容量（0.1-1毫升、1-2毫升、2-5毫升、5-10毫升）、按应用（药物给药、疫苗输送、肠内喂养、灌溉）、按形式（带Luer锁的口服注射器、无Luer锁的口服注射器、带刻度的口服注射器、无刻度的口服注射器）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.37%
- **2024:** $ 1.88 Billion
- **2025:** $ 2 Billion
- **2035:** $ 3.7 Billion
- **Key Players:** BD (US), Medtronic (US), Terumo (JP), Cardinal Health (US), B. Braun (DE), Smiths Medical (US), Nipro (JP), Fresenius Kabi (DE), Halyard Health (US)

**Report ID:** MRFR/HC/27642-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/oral-syringe-market-29357

---

## Market Summary

## **Oral Syringe Market Overview**

As per MRFR analysis, the Oral Syringe Market Size was estimated at 1.88 (USD Billion) in 2024. The Oral Syringe Market Industry is expected to grow from 2.00 (USD Billion) in 2025 to 3.48 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.37% during the forecast period (2025 - 2034).

### **Key Oral Syringe Market Trends Highlighted**

The global oral syringe market is poised for significant growth driven by increasing demand from the healthcare sector. Key drivers include the rise in chronic diseases such as diabetes and cancer, leading to greater self-medication needs. The growing geriatric population, with their increased healthcare requirements, further contributes to market growth. Additionally, advancements in drug delivery technologies have led to the development of innovative oral syringes, offering convenience and improved patient outcomes.

Market opportunities lie in expanding into emerging markets with underserved healthcare needs and leveraging technological advancements to create user-friendly and efficient devices. Recent trends include the adoption of prefilled oral syringes and the integration of smart technologies for dose monitoring and adherence tracking.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Oral Syringe Market Drivers**

### Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases, such as diabetes and cardiovascular diseases, is a major driver of the global oral syringe market. These diseases require frequent and accurate medication administration, which is fueling the demand for oral syringes. According to the World Health Organization (WHO), approximately 1.9 billion people worldwide suffer from cardiovascular diseases, and over 400 million people have diabetes. The increasing prevalence of these diseases is expected to drive the demand for oral syringes, as they provide a convenient and effective method for medication administration.

### Growing Demand for Self-Injection Therapies

The growing demand for self-injection therapies is another key driver of the global oral syringe market. Self-injection therapies offer patients greater flexibility and convenience in managing their health conditions. Oral syringes are commonly used for self-injection of medications such as insulin, growth hormones, and blood thinners. The increasing adoption of self-injection therapies is expected to drive the demand for oral syringes, as they provide a safe and effective method for patients to administer their medications at home.

### Technological Advancements and Innovation

Technological advancements and innovation are also driving the growth of the global oral syringe market. Manufacturers are continuously developing new and improved oral syringes with enhanced features and functionality. For example, some oral syringes are now available with features such as pre-filled doses, automatic needle retraction, and voice guidance. These advancements make oral syringes more user-friendly and convenient for patients, which is expected to drive the demand for these devices in the coming years.

## **Oral Syringe Market Segment Insights**

### **Oral Syringe Market Material Insights  **

Material Segment Overview The Global Oral Syringe Market is segmented based on material into polypropylene, polyethylene, nylon, and polycarbonate. Among these, polypropylene held the dominant position in the market in 2023, accounting for over 40% of the global revenue. Polypropylene is a lightweight, flexible, and durable material that offers high chemical resistance, making it ideal for manufacturing oral syringes.

Polyethylene is another widely used material in the oral syringe market due to its low cost, ease of processing, and good barrier properties.Nylon is a strong and flexible material that provides excellent resistance to wear and tear, making it suitable for syringes that require repeated use.

Polycarbonate is a strong, clear, and lightweight material that offers high impact resistance and dimensional stability, making it suitable for syringes that require precise dosing. The choice of material for oral syringes depends on various factors, including the intended use, compatibility with the drug being administered, and cost considerations. The growth of the oral syringe market is expected to be driven by increasing demand for self-injection therapies, technological advancements in syringe design, and rising healthcare expenditure in developing countries.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Oral Syringe Market Capacity Insights  **

The capacity segment plays a significant role in the global Oral Syringe Market. In 2023, the 0.1-1 ml capacity segment held a notable market share and is projected to maintain its dominance in the coming years. This segment is primarily driven by the widespread use of oral syringes for administering small volumes of liquid medications, such as vaccines and insulin. The 1-2 ml capacity segment is another prominent segment, capturing a significant portion of the market revenue.

It is commonly used for administering larger volumes of medications and fluids, particularly in clinical and hospital settings.The 2-5 ml capacity segment exhibits steady growth due to its suitability for administering larger volumes of fluids and medications, including antibiotics and pain relievers. Lastly, the 5-10 ml capacity segment holds a smaller market share and is primarily utilized for administering larger volumes of fluids and medications, such as blood transfusions and IV fluids. The growth of this segment is expected to be influenced by the increasing demand for fluids and medications in critical care and emergency settings.

### **Oral Syringe Market Application Insights  **

The Application segment of the Global Oral Syringe Market is categorized into Medication Administration, Vaccine Delivery, Enteral Feeding, and Irrigation. Medication Administration is estimated to dominate the segment in 2023, accounting for approximately 75% of the Global Oral Syringe Market revenue, driven by the increasing prevalence of chronic diseases and the rising demand for self-medication. Vaccine Delivery is projected to witness steady growth over the forecast period, owing to the increasing number of vaccination campaigns and the development of novel vaccines.Enteral Feeding is anticipated to expand significantly, fueled by the growing geriatric population and the rising incidence of feeding difficulties.

Irrigation is expected to contribute a notable share to the segment, driven by its applications in dental procedures and wound care.

### **Oral Syringe Market Form Insights  **

The market growth is attributed to the increasing prevalence of chronic diseases, rising awareness about oral hygiene, and growing demand for convenient and effective drug delivery methods. Oral Syringes with Luer Lock accounted for the largest revenue share in 2023, owing to their secure connection and reduced risk of leakage. Graduated Oral Syringes are also gaining popularity due to their ease of use and accurate dosage measurement. The market for Oral Syringes without Graduations is expected to expand at a significant rate, driven by their cost-effectiveness and widespread availability.

### **Oral Syringe Market Regional Insights  **

The Global Oral Syringe Market exhibits regional diversity with varying market dynamics and growth prospects. North America held the dominant position in 2023, capturing a significant share of the global revenue. This dominance is attributed to factors such as advanced healthcare infrastructure, high disposable income, and increasing prevalence of chronic diseases. Europe is another key region, characterized by a mature healthcare system and a large aging population.

The Asia-Pacific (APAC) region is poised for substantial growth, driven by rising disposable income, expanding healthcare access, and a growing awareness of oral hygiene.South America and the Middle East and Africa (MEA) regions offer growth opportunities due to increasing urbanization, improving healthcare systems, and rising disposable income. Understanding the regional segmentation enables stakeholders to tailor their strategies and target specific markets effectively.

.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Oral Syringe Market Key Players And Competitive Insights**

Major players in Oral Syringe Market are constantly striving to gain a competitive edge by developing innovative products and expanding their geographical reach. Leading Oral Syringe Market players are focusing on strategic partnerships, acquisitions, and collaborations to strengthen their market position. The Oral Syringe Market development is driven by factors such as rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and growing awareness about the benefits of oral syringes.

The Oral Syringe Market Competitive Landscape is characterized by the presence of both established and emerging players, each with their own strengths and strategies.Becton, Dickinson and Company is a leading player in the Oral Syringe Market. The company offers a wide range of oral syringes under the BD brand, including insulin syringes, tuberculin syringes, and medication cups. BD is known for its high-quality products and strong distribution network.

The company has a global presence and caters to a diverse customer base. BD is committed to innovation and continuously invests in research and development to improve its product offerings.Terumo Corporation is another major player in the Oral Syringe Market. The company manufactures a variety of oral syringes, including prefilled syringes, safety syringes, and auto-injectors. Terumo is known for its advanced technology and precision engineering. The company has a strong global presence and caters to a wide range of healthcare providers. Terumo is committed to providing high-quality products and services to its customers.

The company is actively involved in research and development to develop new and innovative products that meet the evolving needs of the market.

### **Key Companies in the Oral Syringe Market Include**

## **Oral Syringe Market Developments**

The global oral syringe market is anticipated to grow from USD 1.66 billion in 2023 to USD 2.9 billion by 2032, exhibiting a CAGR of 6.37% during the forecast period 2025-2034. Increasing prevalence of chronic diseases, such as diabetes and cardiovascular diseases, is a major factor driving the growth of the market. Oral syringes are used for accurate and convenient administration of liquid medications, making them essential for patients with chronic conditions. The market is also benefiting from rising awareness about the importance of medication adherence and the convenience of oral syringes.

However, factors such as the availability of alternative drug delivery methods and regulatory complexities may restrain market growth to some extent.

** **

## **Oral Syringe Market Segmentation Insights**

### **Oral Syringe Market Material Outlook**

### **Oral Syringe Market Capacity Outlook**

### **Oral Syringe Market Application Outlook**

### **Oral Syringe Market Form Outlook**

### **Oral Syringe Market Regional Outlook**

## Market Drivers

### 设计中的技术进步

技术进步在塑造口服注射器市场中发挥着关键作用。材料和设计的创新正在导致更易于使用和更准确的口服注射器的发展。例如，带有集成测量标记和符合人体工程学的握把的注射器的推出正在提升用户体验，特别是对于给儿童服药的护理人员。此外，制造工艺的进步使得生产不仅更耐用而且更具成本效益的注射器成为可能。市场数据显示，具有先进设计的口服注射器细分市场预计将以约5%的年增长率增长。这一趋势表明，随着技术的不断发展，口服注射器市场可能会涌现出满足患者和医疗服务提供者特定需求的产品。

### 安全标准的监管支持

口服注射器市场受益于增强的监管支持，旨在提高安全标准。监管机构越来越强调安全用药的重要性，这导致了口服注射器设计和制造的严格指南的建立。这种监管环境促进了创新，因为制造商被迫开发符合这些安全标准的产品。市场数据显示，遵守这些规定可能会推动口服注射器细分市场的增长，预计对具有安全特性的注射器的需求将增加，例如防回流机制和防篡改设计。因此，口服注射器市场预计将看到消费者信心的提升，进一步推动市场扩张，因为医疗服务提供者和患者优先考虑用药安全。

### 对儿科应用的需求上升

口服注射器市场正经历着显著的需求增长，这主要是由于对儿科应用日益增长的需求。随着医疗服务提供者强调儿童准确剂量的重要性，口服注射器在临床和家庭环境中正成为必不可少的工具。专为儿科使用设计的口服注射器市场预计将扩展，估计在未来几年内的年复合增长率约为6%。这种增长归因于儿童慢性疾病的发病率上升，迫切需要精确的药物管理。此外，家长对正确剂量重要性的认识不断提高，可能进一步推动针对年轻患者的口服注射器的需求。因此，制造商正专注于开发创新设计，以提高儿科患者的可用性和安全性。

### 对家庭医疗保健的关注增加

口服注射器市场正在向居家医疗转变，这对市场动态产生了显著影响。随着越来越多的患者在家中接受治疗，而不是在传统医疗环境中，口服注射器的需求预计将上升。这一趋势在老年患者和需要持续药物管理的慢性病患者中尤为明显。市场分析表明，居家医疗细分市场预计在未来几年将以约7%的速度增长，推动这一增长的是对居家治疗选项的日益偏好。因此，制造商正在调整其产品供应，以满足这一不断扩大的市场需求，专注于创造易于使用且能促进准确剂量的口服注射器。这一转变不仅提高了患者的便利性，还与强调以患者为中心的护理的更广泛医疗趋势相一致。

### 对药物依从性日益增长的认识

口服注射器市场正在增长，这得益于患者和医疗提供者对药物依从性认识的提高。随着遵循处方药物方案的重要性被越来越广泛地认可，促进准确剂量的工具需求正在上升。口服注射器在确保患者获得正确剂量方面特别有效，从而提高了依从性。市场研究未来（Market Research Future）指出，专注于增强药物依从性的细分市场预计将以每年约6%的速度增长。这一趋势可能会鼓励制造商创新并开发不仅用户友好而且配备提醒患者按时服药功能的口服注射器。因此，随着利益相关者越来越重视支持药物依从性的解决方案，口服注射器市场有望实现增长。

## Future Outlook

口服注射器市场预计将在2024年至2035年间以6.37%的年均增长率增长，推动因素包括医疗需求的增加和技术进步。

**New opportunities:**

- 开发环保的可生物降解口服注射器

到2035年，口服注射器市场预计将实现强劲增长和增强的市场存在。

## Segment Insights

### 按材料：聚丙烯（最大）与聚碳酸酯（增长最快）

在口服注射器市场中，聚丙烯因其优良的化学耐受性、灵活性和低制造成本而主导材料领域。它的市场份额显著超过聚乙烯、尼龙和聚碳酸酯，使其成为大多数制造商的首选。聚乙烯作为次要材料紧随其后，以其良好的强度和成型特性而受到赞誉，而尼龙和聚碳酸酯则使用较少，但在小众应用中具有影响力。

聚丙烯（主导）与聚碳酸酯（新兴）

聚丙烯仍然是口服注射器市场的主导材料，以其耐用性、易于消毒和成本效益而闻名。其巨大的生产能力和在各种医疗环境中的广泛应用凸显了其重要性。相反，聚碳酸酯正在成为一个关键参与者，特别是在对清晰度和强度要求较高的高性能应用中。其轻便、抗碎裂的特性吸引了追求现代设计和功能性的制造商。尽管仍在获得关注，聚碳酸酯的创新应用可能使其在未来的口服注射器材料中成为强有力的竞争者。

### 按容量：2-5 毫升（最大）与 1-2 毫升（增长最快）

在口服注射器市场中，容量细分展现出多样化的分布，其中2-5毫升类别占据了市场份额的重要部分，表明其在医疗和制药应用中的广泛接受度。同时，1-2毫升容量的注射器在用户中逐渐受到青睐，显示出在儿科和老年护理中对小剂量的日益偏好，从而展现出消费者在量身定制剂量解决方案方面的独特趋势。

这一细分市场的增长趋势显然受到制药应用中对精准剂量需求上升的影响。1-2毫升注射器的市场加速增长是由于药物配方的创新，要求更小的剂量以提高效果。同时，较大的2-5毫升注射器因其在各种治疗干预中的多功能性而受到青睐。总体而言，这些容量细分旨在满足特定人群的需求，同时支持医疗服务提供者进行准确的药物管理。

2-5 毫升（主导）对比 1-2 毫升（新兴）

2-5毫升口服注射器在市场中占据主导容量细分，因其在临床环境中广泛使用以及用于需要较大剂量的各种药物而具有显著特点。它们的坚固性和可靠性使其非常适合成人及需要在治疗环境中精确剂量的患者。相反，1-2毫升细分市场正在迅速崛起，主要受到对儿科配方和老年患者精确剂量需求日益增长的推动。该细分市场迎合了个性化医疗的日益趋势，与优先考虑准确性和患者安全的医疗保健进步相一致。这两个细分市场反映出不同但互补的市场特征，强调了剂量需求不断演变的格局。

### 按应用：药物管理（最大）与疫苗接种（增长最快）

在口服注射器市场中，应用领域主要受到药物给药的影响，该领域因在医院和家庭护理环境中的广泛应用而占据了显著的市场份额。该领域对于液体药物的准确剂量至关重要，促进了口服注射器整体需求的更大部分。相比之下，疫苗输送正在迅速获得关注，特别是在全球对疫苗接种计划日益关注的背景下，这导致对高效和无菌注射器解决方案的需求激增。

药物管理（主导）与灌溉（新兴）

药物管理应用在医疗保健中扮演着至关重要的角色，负责提供精确的液体药物剂量，使其成为口服注射器市场的主导细分市场。其强大之处在于在机构环境和居家护理场景中的高使用率。另一方面，灌溉应用代表了一种新兴趋势，因为在需要灌溉的程序中（如伤口护理和清洁）对注射器的需求正在稳步增加。这是由于人们对医疗实践的更大意识和进步，正在扩大口服注射器的作用，超越传统用途。

### 按形式：带有Luer锁的口服注射器市场（最大）与没有刻度的口服注射器市场（增长最快）

口服注射器市场的特点是产品种类繁多，其中带有Luer Lock的口服注射器是最突出的细分市场，由于其在各种医疗应用中的多功能性和易用性，占据了相当大的市场份额。相比之下，未标度的口服注射器作为增长最快的细分市场正在迅速崛起，特别吸引家庭使用，因为在这种情况下精确测量并不那么关键，从而显著扩大了它们相对于标度口服注射器的市场存在。

口服注射器市场：带锁的鲁尔（主导）与不带刻度的口服注射器市场（新兴）

带有Luer Lock的口服注射器市场因其安全连接能力而受到认可，减少了使用过程中的泄漏风险，使其成为临床环境中的首选。其设计允许轻松连接各种医疗设备，增强了其功能性。相反，未标定的口服注射器市场在需要简单和易用的消费者中越来越受欢迎，尤其是在儿科或非专业环境中进行非精确剂量时。该细分市场因其成本效益和简单设计而具有吸引力，促进了家庭和看护者的采用增加。

## Regional Market Share Analysis

### 北美：创新的市场领导者

北美是口服注射器最大的市场，占全球市场份额的约45%。该地区的增长受到医疗保健支出增加、慢性疾病上升以及对居家医疗解决方案日益偏好的推动。FDA等机构的监管支持进一步促进了市场扩展，确保医疗设备的安全性和有效性。美国在市场中处于领先地位，其次是加拿大，BD、美敦力和凯德尔健康等主要企业主导着市场格局。竞争环境的特点是这些公司之间持续的创新和战略合作，增强了产品供应和市场覆盖。

### 欧洲：监管框架促进增长

欧洲是口服注射器的第二大市场，约占全球市场份额的30%。该地区受益于严格的监管框架，确保医疗设备的高质量标准。对患者安全的日益关注和慢性疾病的上升是重要的增长驱动因素。欧洲药品管理局（EMA）在监管和批准新产品方面发挥着关键作用，促进了该领域的创新。主要国家包括德国、法国和英国，B. Braun和费森尤斯·卡比等主要企业在市场上稳固立足。竞争格局的特点是对技术进步的关注以及制造商之间的合作，以提高产品效率和安全性，确保强大的市场存在。

### 亚太地区：具有高潜力的新兴市场

亚太地区是口服注射器市场的新兴强国，约占全球市场份额的20%。该地区的增长受到医疗保健投资增加、老年人口上升和医疗服务可及性扩展的推动。各国政府正在实施政策以改善医疗基础设施，这预计将进一步推动对口服注射器的需求。日本、中国和印度等国在这一增长中处于前沿，Terumo和Nipro等主要企业在市场中处于领先地位。竞争格局正在演变，本地制造商与已建立的全球公司一起获得了市场份额，推动了产品的创新和可负担性。

### 中东和非洲：未开发的市场与增长机会

中东和非洲代表了口服注射器市场的资源丰富的前沿，约占全球市场份额的5%。该地区的医疗支出逐渐增加，受到政府改善医疗可及性和质量的倡议推动。疾病的上升流行和对患者安全的日益关注是推动市场增长的关键因素。主要国家包括南非和阿联酋，医疗改革为市场进入创造了机会。竞争格局的特点是本地和国际企业的混合，企业专注于扩大分销网络和提高产品可用性，以满足日益增长的需求。

## Competitive Benchmarking

口服注射器市场目前的特点是动态的竞争格局，受到对精确药物输送需求增加和对患者安全日益重视的驱动。BD（美国）、美敦力（美国）和B. Braun（德国）等主要参与者在战略上定位，以利用创新和技术进步。BD（美国）专注于通过持续创新来增强其产品组合，而美敦力（美国）则强调战略合作伙伴关系以扩大市场覆盖。B. Braun（德国）积极追求区域扩张，特别是在新兴市场，这共同塑造了一个越来越关注质量和可靠性的竞争环境。

在商业策略方面，公司正在本地化制造以降低成本并优化供应链，这在全球经济波动的背景下尤为相关。口服注射器市场似乎适度分散，既有成熟的参与者，也有新兴公司。这些主要参与者的集体影响力显著，因为他们推动行业标准和创新，从而增强整体市场竞争力。

2025年8月，BD（美国）宣布推出一系列新型口服注射器，设计上具有增强的安全特性，旨在减少用药错误。这一战略举措不仅强化了BD对患者安全的承诺，还将公司定位为口服注射器领域的创新领导者。这些注射器的推出可能会吸引寻求可靠解决方案的医疗服务提供者，从而增强BD的市场份额。

2025年9月，美敦力（美国）与一家领先的数字健康公司达成合作，旨在将基于人工智能的分析集成到其口服注射器输送系统中。这一合作具有重要意义，因为它反映了医疗保健数字化的更广泛趋势，可能通过更准确的剂量和监测改善患者结果。这种战略联盟可能通过提供满足医疗服务提供者不断变化需求的先进解决方案来增强美敦力的竞争优势。

2025年7月，B. Braun（德国）在亚洲扩大了其制造能力，旨在满足该地区对口服注射器日益增长的需求。这一扩张在战略上非常重要，因为它不仅增加了生产能力，还使B. Braun能够更有效地响应当地市场需求。通过增强其运营足迹，B. Braun可能会提高其供应链效率并缩短交货时间，这些都是维持竞争力的关键因素。

截至2025年10月，口服注射器市场正在见证数字化、可持续性和人工智能技术整合等趋势。这些趋势正在重塑竞争格局，各公司越来越多地形成战略联盟以增强其产品。由基于价格的竞争转向关注创新、技术和供应链可靠性的转变显而易见，这表明未来的竞争差异化将取决于提供符合医疗保健行业不断变化需求的优质产品和服务的能力。

## Recent News & Developments

全球口服注射器市场预计将从2023年的16.6亿美元增长到2032年的29亿美元，在2025-2034年的预测期内，年均增长率为6.37%。慢性疾病（如糖尿病和心血管疾病）的患病率增加是推动市场增长的主要因素。口服注射器用于准确和方便地给药液体药物，使其对慢性病患者至关重要。市场还受益于对药物依从性重要性和口服注射器便利性的日益关注。

然而，替代药物递送方法的可用性和监管复杂性等因素可能在一定程度上抑制市场增长。

## Report Scope

| 2024年市场规模 | 1.878（十亿美元） |
| --- | --- |
| 2025年市场规模 | 1.997（十亿美元） |
| 2035年市场规模 | 3.704（十亿美元） |
| 复合年增长率（CAGR） | 6.37%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 对儿科和老年护理中精确剂量输送的需求增长，增强了口服注射器市场的机会。 |
| 主要市场动态 | 对儿科护理中精确剂量的需求上升，推动了口服注射器市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 截至2024年，口服注射器市场的当前估值是多少？**
A: 2024年口服注射器市场的价值为18.78亿美元。

**Q: 到2035年，口服注射器市场的预计市场规模是多少？**
A: 预计到2035年，市场将达到37.04亿美元。

**Q: 在2025年至2035年的预测期内，口服注射器市场的预期CAGR是多少？**
A: 2025年至2035年口服注射器市场的预期CAGR为6.37%。

**Q: 哪些材料主导了口服注射器市场？**
A: 聚丙烯和聚碳酸酯是领先材料之一，预计在2024年的估值分别为5.63亿美元和7.52亿美元。

**Q: 口服注射器市场的容量细分表现如何？**
A: 2024年，1-2毫升和2-5毫升容量段的估值均为5.63亿美元。

**Q: 哪些应用正在推动口服注射器市场的增长？**
A: 药物管理是一个关键应用，预计在2024年价值为9.43亿美元。

**Q: 市场上有哪些类型的口服注射器？**
A: 带和不带Luer Lock的口服注射器是显著的形式，预计在2024年的估值分别为5.63亿美元和5.63亿美元。

**Q: 口服注射器市场的关键参与者是谁？**
A: 主要参与者包括BD、美敦力、Terumo和Cardinal Health等。

**Q: 口服注射器市场的增长潜力是什么？**
A: 市场似乎具有可观的增长潜力，预计从2024年到2035年几乎将翻一番。

**Q: 口服注射器市场在不同细分市场中的比较如何？**
A: 市场在各个细分领域表现不一，药物管理领先，其次是疫苗配送。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/oral-syringe-market-29357*